Percutaneous PTNS versus drugs | | |
---|
| Number of papers identified | 589 |
| Number of papers excluded | 0 |
| Number of papers included | 1 |
What is the effectiveness of Botulinum toxin A (200U) when compared to Botulinum toxin A (100U) | | |
---|
| Number of papers identified | 785 |
| Number of papers excluded | 21 |
| Number of papers included | 4 |
What is the effectiveness of Botulinum toxin A (200U) when compared to Botulinum toxin A (100U) | | |
---|
| Number of papers identified | 784 |
| Number of papers excluded | 21 |
| Number of papers included | 2 |
HEALTH ECONOMIC GLOBAL SEARCH (RESULTS OF DECEMBER RERUN SEARCH) | | |
---|
| Number of papers identified | 384 |
| Number of papers weeded out | 371 |
| Number of papers received* | 15 |
| Number of papers excluded | 4 |
| Number of papers included | 1 |
In women with OAB, what is the comparative effectiveness of pharmacological interventions? | | |
---|
| Number of papers identified | 1325 |
| Number of papers excluded | 80 |
| Number of papers included | 48 |
Percutaneous PTNS vs NAT for OAB | | |
---|
| Number of papers identified | 590 |
| Number of papers excluded | 18 |
| Number of papers included | 3 |
Neuromodulation. HEALTH ECONOMICS | | |
---|
| Number of papers identified | 102 |
| Number of papers weeded out | 74 |
| Number of papers received* | 6 |
| Number of papers excluded | 1 |
| Number of papers included | 3 |
Transcutaneoous PTNS for OAB | | |
---|
| Number of papers identified | 589 |
| Number of papers excluded | 9 |
| Number of papers included | 2 |
What is the comparative effectiveness of surgical approaches for mid-urethral procedures in women undergoing their primary surgical tape procedure? HEALTH ECONOMICS | | |
---|
| Number of papers identified | 142 |
| Number of papers weeded out | 134 |
| Number of papers received* | 6 |
| Number of papers excluded | 7 |
| Number of papers included | 1 |
Sacral nerve stimulation vs NAT for OAB | | |
---|
| Number of papers identified | 736 |
| Number of papers excluded | 10 |
| Number of papers included | 0 |
What is the comparative effectiveness of interventions for women with failure of the primary tape procedure? HEALTH ECONOMIC | | |
---|
| Number of papers identified | 127 |
| Number of papers weeded out | 50 |
| Number of papers received* | 0 |
| Number of papers excluded | 0 |
| Number of papers included | 0 |
SNS vs PTNS for OAB | | |
---|
| Number of papers identified | 429 |
| Number of papers excluded | 0 |
| Number of papers included | 0 |
What is the effectiveness of Botulinum toxin A (200U) when compared to placebo | | |
---|
| Number of papers identified | 784 |
| Number of papers excluded | 21 |
| Number of papers included | 5 |
What is the comparative effectiveness of surgical approaches for mid-urethral procedures in women undergoing their primary surgical tape procedure? | | |
---|
| Number of papers identified | 2584 |
| Number of papers excluded | 61 |
| Number of papers included | 38 |
What is the long-term effectiveness of surgical approaches for mid-urethral procedures in women undergoing their primary surgical tape procedure? | | |
---|
| Number of papers identified | 2580 |
| Number of papers excluded | 78 |
| Number of papers included | 20 |
What is the comparative effectiveness of interventions for women with failure of the primary tape procedure? | | |
---|
| Number of papers identified | 2521 |
| Number of papers excluded | 19 |
| Number of papers included | 15 |
What patient characteristics are predictors of primary tape failure | | |
---|
| Number of papers identified | 2522 |
| Number of papers excluded | 26 |
| Number of papers included | 6 |
Drugs for OAB - Health Economics | | |
---|
| Number of papers identified | 109 |
| Number of papers weeded out | 0 |
| Number of papers received* | 0 |
| Number of papers excluded | 0 |
| Number of papers included | 5 |
Drugs vs Neuro vs BoNT-A for OAB caused by DOA. HEALTH ECONOMICS | | |
---|
| Number of papers identified | 55 |
| Number of papers weeded out | 45 |
| Number of papers received* | 7 |
| Number of papers excluded | 1 |
| Number of papers included | 2 |